https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-ojemda-tovorafenib-relapsed-or-refractory-pediatric-low-grade
FDA D.I.S.C.O. Burst Edition: FDA approval of Ojemda (tovorafenib) for relapsed or refractory...
Listen to a soundcast of the April 23, 2024, FDA approval of Ojemda (tovorafenib) for relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion...